| Financial Year |
March 31 2023 |
| Monetary Funds |
7,510,093,559.13 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
954,364,350.08 |
| Accounts Receivable |
547,128,683.25 |
| Advances to Suppliers |
4,394,183,301.63 |
| Other Receivables |
105,614,577.34 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
10,073,268,341.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
16,740,000.00 |
| Other Current Assets |
233,418,811.47 |
| Total Current Assets |
23,927,120,108.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
80,500,000.00 |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
27,108,810,087.16 |
| Under-construction Projects |
2,628,509,027.09 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,165,106,320.69 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
360,642,325.68 |
| Other Non-Current Assets |
706,932,699.39 |
| Sub-Total of Non-Current Assets |
32,054,523,112.61 |
| Total Assets |
55,981,643,220.95 |
| Short-Term Loans |
5,091,918,970.84 |
| Trading Financial liabilities |
-- |
| Notes Payable |
10,085,774,879.57 |
| Accounts Payable |
1,737,841,894.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
48,672,187.32 |
| Taxes Payable |
1,528,223,061.17 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
1,013,384,168.88 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,048,064,310.32 |
| Other Current Liabilities |
693,629,457.83 |
| Sub-Total of Current Liabilities |
23,300,966,505.37 |
| Long-term Loans |
7,915,875,730.43 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
907,986,082.70 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
70,607,325.11 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,335,668,638.98 |
| Total Liabilities |
32,636,635,144.35 |
| Paid-In Capital(Or Share Stock) |
4,651,885,415.00 |
| Capital Surplus |
8,871,378,943.80 |
| Surplus Reserve |
722,366,543.47 |
| LESS:Treasury Stock |
150,014,785.90 |
| Undistributed Profits |
9,243,941,961.34 |
| Minority Stockholder's Interest |
6,441,959.04 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
23,338,566,117.56 |
| Owner's Equity（Stockholder's Equity） |
23,345,008,076.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
55,981,643,220.95 |
